Because B7-H3, an immune checkpoint protein, is markedly enriched in TSC-associated tumors, we sought to determine the impact of B7-H3 on the growth of TSC2-deficient tumors using our previously established models in which Tsc2-deficient cells (105K and TTJ) are subcutaneously (s.c.)inoculated into syngeneic mice43. The gene discussed is TSC2; the disease is tuberous sclerosis.